4JPW image
Deposition Date 2013-03-19
Release Date 2013-04-17
Last Version Date 2024-11-20
Entry Detail
PDB ID:
4JPW
Title:
Crystal structure of broadly and potently neutralizing antibody 12a21 in complex with hiv-1 strain 93th057 gp120 mutant
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.90 Å
R-Value Free:
0.26
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HIV-1 CLADE A/E STRAIN 73TH057 GP120 WITH MUTATION H375S
Mutations:H375S
Chain IDs:A (auth: G)
Chain Length:353
Number of Molecules:1
Biological Source:HUMAN IMMUNODEFICIENCY VIRUS 1
Polymer Type:polypeptide(L)
Molecule:HEAVY CHAIN OF ANTIBODY 12A21
Chain IDs:B (auth: H)
Chain Length:225
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:LIGHT CHAIN OF ANTIBODY 12A21
Chain IDs:C (auth: L)
Chain Length:210
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Primary Citation

Abstact

Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance for HIV-1 vaccine design. Notably, bNAbs are highly somatically mutated and generated by a fraction of HIV-1-infected individuals several years after infection. Antibodies typically accumulate mutations in the complementarity determining region (CDR) loops, which usually contact the antigen. The CDR loops are scaffolded by canonical framework regions (FWRs) that are both resistant to and less tolerant of mutations. Here, we report that in contrast to most antibodies, including those with limited HIV-1 neutralizing activity, most bNAbs require somatic mutations in their FWRs. Structural and functional analyses reveal that somatic mutations in FWR residues enhance breadth and potency by providing increased flexibility and/or direct antigen contact. Thus, in bNAbs, FWRs play an essential role beyond scaffolding the CDR loops and their unusual contribution to potency and breadth should be considered in HIV-1 vaccine design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures